Skip to main content
DNA Labs India

PNPT1 Gene Combined oxidative phosphorylation deficiency type 13 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

PNPT1 Gene Combined oxidative phosphorylation deficiency type 13 NGS Genetic Test

Short Name: PNPT1 Gene COXPD13 NGS Test

Also known as: PNPT1 Gene NGS Test, COXPD13 Genetic Test, PNPT1 Mutation Analysis, Combined Oxidative Phosphorylation Deficiency Type 13 DNA Test, Mitochondrial Disorder Genetic Panel - PNPT1

PNPT1 Gene Combined oxidative phosphorylation deficiency type 13 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks from sample receipt at the laboratory. Free home collection in 300+ cities across India.

Next-Generation Sequencing (NGS) Genetic TestAll Age Groups🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the PNPT1 Gene COXPD13 NGS Genetic Test is to identify pathogenic or likely pathogenic mutations in the PNPT1 gene that cause combined oxidative phosphorylation deficiency type 13. This test aids in confirming a clinical diagnosis of COXPD13, differentiating it from other mitochondrial or metabolic disorders, guiding appropriate clinical management, enabling genetic counseling for affected families, and informing recurrence risk assessment for future pregnancies.

Test Code
1935
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks from sample receipt at the laboratory
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation such as fasting is required. Patients should bring a referral from their healthcare provider and relevant clinical history documentation.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample of 3-5 mL is collected via venipuncture into an EDTA vacutainer tube. Alternatively, one drop of blood on an FTA card or extracted DNA may be submitted. The procedure takes approximately 5-10 minutes.

Step 3

Report Delivery

Apply pressure to the puncture site with a cotton ball for a few minutes. There are no activity restrictions post blood draw. Reports will be available in 3 to 4 weeks.

Timeline: 3 to 4 Weeks from sample receipt at the laboratory

Patient Instructions

1
Before the Test:No special preparation or fasting is required. Ensure that a genetic counseling session has been conducted to draw a pedigree chart of family members affected with COXPD13 or related metabolic disorders. Provide detailed clinical history of the patient to the testing laboratory.
2
During the Test:A blood sample will be collected via venipuncture or via one drop of blood on an FTA card. The sample collection process is quick and minimally invasive, typically taking less than 10 minutes.
3
After the Test:After sample collection, there are no restrictions. The sample will be processed for NGS-based sequencing of the PNPT1 gene. Results will be available in 3 to 4 weeks via the online portal, email, or WhatsApp.

About This Test

Who Should Get This Test

The purpose of the PNPT1 Gene COXPD13 NGS Genetic Test is to identify pathogenic or likely pathogenic mutations in the PNPT1 gene that cause combined oxidative phosphorylation deficiency type 13. This test aids in confirming a clinical diagnosis of COXPD13, differentiating it from other mitochondrial or metabolic disorders, guiding appropriate clinical management, enabling genetic counseling for affected families, and informing recurrence risk assessment for future pregnancies.

How to Prepare

  • No fasting is required before sample collection.
  • Bring a valid photo ID and the healthcare provider's referral or prescription.
  • Inform the phlebotomist of any blood-thinning medication use.
  • EDTA (Lavender Top) vacutainer is the preferred collection tube.
  • Avoid heparin-based anticoagulants as they can interfere with downstream molecular analysis.
  • If using an FTA card, ensure proper drying before packaging.
  • Sample should be stored and transported at ambient room temperature.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"PNPT1 gene mutations causing COXPD13 are rare but clinically significant, particularly when there is a family history of mitochondrial dysfunction. Early genetic diagnosis through NGS allows families to understand recurrence risks and access supportive care. I recommend this test for any patient presenting with unexplained multisystem mitochondrial symptoms and a suspected genetic basis. Genetic counseling before and after testing is strongly advised."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL
ContainerEDTA Vacutainer (Lavender Top) or FTA Card
Collection MethodVenipuncture

Sample Stability

Sample Rejection Criteria:
  • Heparinized blood sample
  • Clotted or hemolyzed blood sample
  • Insufficient sample volume
  • Sample without proper labeling or identification
  • Contaminated or degraded DNA sample

Understanding Your Results

The results of the PNPT1 Gene COXPD13 NGS Genetic Test will indicate whether pathogenic or likely pathogenic mutations were detected in the PNPT1 gene. A positive result confirms a molecular diagnosis of combined oxidative phosphorylation deficiency type 13 and should be interpreted in the context of the patient's clinical presentation and family history by a qualified geneticist or genetic counselor.
📊

Pathogenic Variant(s) Detected

One or more pathogenic or likely pathogenic mutations in the PNPT1 gene were identified. This result supports a molecular diagnosis of COXPD13. Clinical correlation and genetic counseling are recommended.

Action: Consult with a geneticist or genetic counselor for clinical management and family risk assessment.

📊

No Pathogenic Variants Detected

No pathogenic or likely pathogenic variants were identified in the PNPT1 gene. This result reduces the likelihood of COXPD13 but does not exclude other genetic causes of the patient's symptoms.

Action: Discuss with the referring physician whether additional genetic testing is indicated.

📊

Variant of Uncertain Significance (VUS) Identified

A variant of uncertain significance was detected in the PNPT1 gene. The clinical relevance of this variant cannot be determined with current evidence.

Action: Clinical correlation, family segregation studies, and periodic re-evaluation of variant classification are recommended.

⚠️ When to Consult a Doctor:

Consult your healthcare provider or geneticist if you or your child experience unexplained developmental delay, chronic weakness and fatigue, difficulty breathing, muscle stiffness, heart problems, or abnormal liver function that may be suggestive of a mitochondrial disorder. If you have a family history of combined oxidative phosphorylation deficiency or other mitochondrial diseases, genetic counseling and testing should be discussed with your doctor.

Limitations

  • This test does not detect large genomic rearrangements or copy number variations (CNVs) unless specifically included in the analysis pipeline.
  • Variants of Uncertain Significance (VUS) may be reported and may require further evaluation.
  • This test is specific to the PNPT1 gene and does not screen for other mitochondrial disease-associated genes.
  • A negative result does not completely exclude a genetic cause for the patient's symptoms if mutations lie in regulatory or deep intronic regions not covered by NGS.

Risks & Considerations

  • Minor bruising or discomfort at the venipuncture site
  • Rare risk of infection at the puncture site
  • Emotional impact of genetic test results; genetic counseling is recommended to address psychological concerns

Interfering Factors

  • Degraded or low-quality DNA extracted from improperly stored samples
  • Heparin contamination in the blood sample (EDTA is preferred)
  • Sample mix-up or incorrect patient identification
  • Presence of somatic mosaicism may limit detection sensitivity

Compare With Similar Tests

TestPNPT1 Gene Combined oxidative phosphorylation deficiency type 13 NGS Genetic TestWhole Mitochondrial Genome SequencingWhole Exome Sequencing (WES)Respiratory Chain Enzyme Assay
ComparisonPNPT1 Gene Combined oxidative phosphorylation deficiency type 13 NGS Genetic Test

Frequently Asked Questions

What is the PNPT1 Gene Combined Oxidative Phosphorylation Deficiency Type 13 NGS Genetic Test?
This is a next-generation sequencing (NGS) based genetic test that analyzes the PNPT1 gene to detect mutations causing combined oxidative phosphorylation deficiency type 13 (COXPD13), a rare mitochondrial disorder that impairs the body's energy production.
What is COXPD13 and how does it affect the body?
Combined oxidative phosphorylation deficiency type 13 (COXPD13) is a rare genetic disorder caused by mutations in the PNPT1 gene. It affects mitochondrial function, reducing the body's ability to produce cellular energy. This can lead to developmental delay, muscle weakness, heart problems, breathing difficulties, and abnormal liver function.
What are the common symptoms of COXPD13?
Symptoms of COXPD13 can vary widely from person to person. Common symptoms include developmental delay, weakness and fatigue, difficulty breathing, muscle weakness and stiffness, heart problems, and abnormal liver function. Some individuals may experience severe symptoms while others may have only mild manifestations.
How is COXPD13 diagnosed?
COXPD13 is diagnosed through genetic testing, specifically through next-generation sequencing (NGS) of the PNPT1 gene. NGS allows for rapid and accurate identification of mutations associated with the disorder. Clinical evaluation and biochemical testing may also support the diagnosis.
What sample type is required for the PNPT1 Gene NGS Test?
The test can be performed using a blood sample (3-5 mL in an EDTA vacutainer), extracted DNA, or one drop of blood on an FTA card. Your healthcare provider or the sample collection team will guide you on the appropriate sample type.
How much does the PNPT1 Gene NGS Test cost in India?
The cost of the PNPT1 Gene Combined Oxidative Phosphorylation Deficiency Type 13 NGS Genetic Test at DNA Labs India is INR 20,000. This cost includes sample collection, NGS analysis, and the clinical report. Free home sample collection is available across India.
How long does it take to receive the test results?
The turnaround time for the PNPT1 Gene NGS Test is 3 to 4 weeks from the date of sample receipt at the laboratory. Results will be shared via the online portal, email, or WhatsApp.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for the PNPT1 Gene COXPD13 NGS Genetic Test for online bookings. This service is available across numerous cities in India including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, and many more.
Do I need to fast before this genetic test?
No, fasting is not required for the PNPT1 Gene NGS Genetic Test. You can eat and drink normally before sample collection.
Who should consider getting this genetic test?
This test is recommended for individuals presenting with symptoms suggestive of a mitochondrial disorder such as unexplained developmental delay, chronic weakness, muscle stiffness, breathing difficulties, heart problems, or abnormal liver function. It is also recommended for individuals with a family history of COXPD13 or related oxidative phosphorylation deficiencies.
What is the role of the PNPT1 gene in the body?
The PNPT1 gene provides instructions for making a protein involved in the processing of RNA molecules. RNA processing is essential for the production of functional proteins that carry out various cellular functions. Mutations in this gene impair mitochondrial function, leading to combined oxidative phosphorylation deficiency type 13 (COXPD13).
Is genetic counseling recommended before taking this test?
Yes, a genetic counseling session is strongly recommended before and after the PNPT1 Gene NGS Test. Genetic counseling helps in drawing a pedigree chart of affected family members, understanding the implications of test results, assessing recurrence risks, and making informed decisions about clinical management and family planning.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.